Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors.

Autor: Su X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lu X; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France.; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China., Bazai SK; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France., Dainese L; Department of Pathology, Hôpital Armand Trousseau, Assistance-Publique Hôpitaux de Paris, Sorbonne Université, Paris, France.; UF Tumorothèque HUEP, Hôpital Armand Trousseau, Assistance-Publique Hôpitaux de Paris, Sorbonne Université, Paris, France.; Centre de Recherche Saint-Antoine (CRSA), INSERM, Sorbonne Université, UMR_S .938, Paris, France., Verschuur A; Department of Pediatric Oncology, Hôpital d'Enfants de La Timone, F-13005, Marseille, France., Dumont B; Centre Léon Bérard, Institut d'Hématologie et d'Oncologie Pédiatrique (IHOPe), Lyon, France., Mouawad R; Department of Medical Oncology, Groupe Hospitalier Pitié-Salpêtrière, Assistance-Publique Hôpitaux de Paris, Paris, France., Xu L; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China., Cheng W; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China., Yan F; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China., Irtan S; Department of Pediaric Surgery, AP-HP, Hôpital Armand Trousseau, Sorbonne Université, Paris, France., Lindner V; Department of Pathology, CHRU Strasbourg, Strasbourg, France., Paillard C; Department of Pediatric Onco-hematology, CHRU Strasbourg, Strasbourg Université, Strasbourg, France., Le Bouc Y; Centre de Recherche Saint-Antoine (CRSA), INSERM, Sorbonne Université, UMR_S .938, Paris, France., Coulomb A; Department of Pathology, Hôpital Armand Trousseau, Assistance-Publique Hôpitaux de Paris, Sorbonne Université, Paris, France. coulomb@aphp.fr.; UF Tumorothèque HUEP, Hôpital Armand Trousseau, Assistance-Publique Hôpitaux de Paris, Sorbonne Université, Paris, France. coulomb@aphp.fr.; Centre de Recherche Saint-Antoine (CRSA), INSERM, Sorbonne Université, UMR_S .938, Paris, France. coulomb@aphp.fr., Malouf GG; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France. maloufg@igbmc.fr.; Department of Medical Oncology, Institut de Cancérologie de Strasbourg, Strasbourg University, Strasbourg, France. maloufg@igbmc.fr.

Publikováno v: Nature communications [Nat Commun] 2023 Nov 30; Vol. 14 (1), pp. 7884. Date of Electronic Publication: 2023 Nov 30.

An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas.

Autor: Lu X; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France.; State Key Laboratory of Natural Medicines, Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Vano Y; Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP, Université Paris Cité, Paris, France., Helleux A; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France., Su X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lindner V; Department of Pathology, Strasbourg University Hospital, Strasbourg, France., Davidson G; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France., Mouawad R; Department of Medical Oncology, Sorbonne University, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France., Spano JP; Department of Medical Oncology, Sorbonne University, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France., Rouprêt M; Department of Urology, Sorbonne University, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France., Elaidi R; Association pour la Recherche sur les Thérapeutiques Innovantes en Cancérologie, Paris, France., Compérat E; Department of Pathology, Sorbonne University, AP-HP, Hôpital Tenon, Paris, France., Verkarre V; Department of Pathology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP, Université Paris Cité, Paris, France., Sun C; Centre des Cordeliers, INSERM, Université de Paris Cité, Sorbonne Université, Paris, France., Chevreau C; Department of Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Bennamoun M; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France., Lang H; Department of Urology, Strasbourg University Hospital, Strasbourg, France., Tricard T; Department of Urology, Strasbourg University Hospital, Strasbourg, France., Cheng W; State Key Laboratory of Natural Medicines, Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Xu L; State Key Laboratory of Natural Medicines, Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Davidson I; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France., Yan F; State Key Laboratory of Natural Medicines, Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Fridman WH; Centre de Recherche des Cordeliers, INSERM, Université Paris Cité, Sorbonne Université, Equipe labellisée Ligue contre le Cancer, Paris, France., Sautes-Fridman C; Centre de Recherche des Cordeliers, INSERM, Université Paris Cité, Sorbonne Université, Equipe labellisée Ligue contre le Cancer, Paris, France., Oudard S; Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP, Université Paris Cité, Paris, France., Malouf GG; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France.; Department of Medical Oncology, Strasbourg University, Institut de Cancérologie de Strasbourg, Strasbourg, France.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Apr 03; Vol. 29 (7), pp. 1279-1291.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PSYCHOLOGICAL SIDE EFFECTS INDUCED BY INTERLEUKIN-2/α INTERFERON TREATMENT.

Autor: Smith, M. J.¹, Mouawad, R.¹, Vuillemin, E.¹, Benhammouda, A.¹, Soubrane, C.¹, Khayat, D.¹

Publikováno v: Psycho-Oncology. Dec1994, Vol. 3 Issue 4, p289-298. 10p.

Population biology of an endangered species: the common guitarfish Rhinobatos rhinobatos in Lebanese marine waters of the eastern Mediterranean Sea

Autor: Lteif, M., Mouawad, R., Khalaf, G., Lenfant, P., Verdoit-Jarraya, M.

Publikováno v: Journal of Fish Biology
Journal of Fish Biology, Wiley, 2016, 88 (4), pp.Pages 1441-1459 ⟨10.1111/jfb.12921⟩

International audience; This study focuses on the population biology of the common guitarfish Rhinobatos rhinobatos, a cartilaginousfish listed as Endangered in the International Union for the Conservation of Nature (IUCN)Red List. Between December 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a52a8ffe36b08777609dd105eb92a7ac
https://hal-univ-perp.archives-ouvertes.fr/hal-01305100